BioNano Genomics Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS

Ticker Exchange SIC # Website Latest Ticker
BNGO Nasdaq 3826 https://bionanogenomics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioNano Genomics Inc

Bionano Announces First Study Using OGM to Discover Structural Variants with Potential Relevance to Genetic Diagnosis of MRKH Syndrome, a Syndrome Impacting Reproductive System Development in 1 in 4,500 Females - Mar 22nd, 2023 12:00 pm
Buy This Magnificent Growth Stock Before It's Too Late - Mar 16th, 2023 1:57 pm
Bionano Laboratories Expands its Clinical Testing Menu with Launch of OGM-Based Laboratory Developed Tests (LDTs) for Prenatal and Postnatal Analysis - Mar 15th, 2023 12:00 pm
Bionano Genomics’ $2.1 million in cash in SVB accounts is part of $113.2 million in cash, cash equivalents and AFS securities - Mar 13th, 2023 2:40 pm
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Featuring OGM Utility Across a Broad Range of Research Applications - Mar 13th, 2023 12:00 pm
Q4 2022 Bionano Genomics Inc Earnings Call - Mar 10th, 2023 2:22 pm
Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript - Mar 10th, 2023 2:30 am
Bionano Genomics, Inc. (BNGO) Reports Q4 Loss, Misses Revenue Estimates - Mar 9th, 2023 10:35 pm
Bionano Genomics Reports Fourth Quarter and Full-Year 2022 Results and Provides Revenue Outlook for 2023 - Mar 9th, 2023 9:05 pm
Is Bionano Genomics Stock a Buy Now? - Mar 7th, 2023 2:45 pm
The Bionano Genomics, Inc. (NASDAQ:BNGO) Analysts Have Been Trimming Their Sales Forecasts - Mar 5th, 2023 12:20 pm
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over Fist - Mar 2nd, 2023 2:13 pm
Bionano Announces Two Publications from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing including the First Peer-Reviewed Publication on the Multi-Site Evaluation of OGM Against SOC - Mar 2nd, 2023 1:00 pm
7 Stocks to Buy on Weakness While You Can - Mar 1st, 2023 5:49 pm
Will ChromaDex (CDXC) Report Negative Earnings Next Week? What You Should Know - Mar 1st, 2023 3:00 pm
Bionano to Report Fourth Quarter and Year End 2022 Financial Results and Host a Conference Call and Webcast March 9, 2023 - Mar 1st, 2023 1:00 pm
Analysts Estimate Bionano Genomics, Inc. (BNGO) to Report a Decline in Earnings: What to Look Out for - Feb 28th, 2023 3:00 pm
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023 - Feb 28th, 2023 2:45 pm
Bionano to Present at the 43rd Annual Cowen Healthcare Conference - Feb 27th, 2023 1:00 pm
Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies - Feb 22nd, 2023 1:00 pm